SUPRAFLEX CRUZ PMCF Study ( rEpic05 )
Condition(s):Coronary Artery Disease (CAD); Ischemic Heart DiseaseLast Updated:March 20, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Coronary Artery Disease (CAD); Ischemic Heart DiseaseLast Updated:March 20, 2024Recruiting
Condition(s):Coronary DiseaseLast Updated:March 6, 2024Recruiting
Condition(s):Coronary StenosisLast Updated:December 17, 2020Completed
Condition(s):Coronary Artery DiseaseLast Updated:July 12, 2023Completed
Condition(s):Coronary Artery Disease; Myocardial Ischemia; Coronary Disease; Heart Diseases; Cardiovascular Diseases; Arterial Occlusive Diseases; Vascular DiseasesLast Updated:April 28, 2023Recruiting
Condition(s):Cardiac Disease; PCI; High Bleeding RiskLast Updated:September 15, 2023Completed
Condition(s):Coronary Artery DiseaseLast Updated:August 21, 2023Recruiting
Condition(s):Percutaneous Coronary Intervention (PCI); Atrial Fibrillation (AF); Oral Anticoagulation; P2Y12 InhibitorLast Updated:January 12, 2024Recruiting
Condition(s):Coronary Artery Disease; Coronary Stenosis; Stent Restenosis; Left Main Coronary Artery Disease; Chronic Total Occlusion of Coronary ArteryLast Updated:January 24, 2022Recruiting
Condition(s):Myocardial InfarctionLast Updated:March 31, 2023Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.